0001209191-21-015098.txt : 20210301 0001209191-21-015098.hdr.sgml : 20210301 20210301103441 ACCESSION NUMBER: 0001209191-21-015098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210209 FILED AS OF DATE: 20210301 DATE AS OF CHANGE: 20210301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bisker-Leib Vered CENTRAL INDEX KEY: 0001814093 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39696 FILM NUMBER: 21695329 MAIL ADDRESS: STREET 1: C/O COMPASS STREET 2: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-09 0 0001738021 Compass Therapeutics, Inc. CMPX 0001814093 Bisker-Leib Vered C/O COMPASS THERAPEUTICS 80 GUEST STREET, SUITE 601 BOSTON MA 02135 0 1 0 0 President & COO Stock Option (Right to Buy) 5.00 2021-02-09 4 A 0 400000 0.00 A 2031-02-09 Common Stock 400000 400000 D 25% of this option vests on February 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter. /s/ Vered Bisker-Leib 2021-03-01